Clinical Pathology Faculty

	Jack B. Alperin, M.D., F.A.C.P. The clinical investigation of problems related to benign diseases of the blood (e.g. hemostasis & thrombosis, hemoglobinopathies, anemia, thrombocytopenia).
	Barbara Jean Bryant, MD, FCAP, FASCP Areas of research include assuring optimal iron balance in volunteer blood donors, hemoglobinopathies, sickle trait donor units, and granulocytapheresis concentrates.
	Jianli Dong, M.D., Ph.D. (1) BRAF/MEK/ERK and p16/CDK/RB pathways in cancer biology. (2) Molecular diagnostics and translation research. Research and development of molecular biomarkers in clinical application.
	Vicki S. Freeman, Ph.D., MT(ASCP)SC My goal is to provide leadership in clinical laboratory science education across the nation. I believe that it is important to provide quality laboratory practitioners for clinical laboratories.
	Alexander J. Indrikovs, M.D. our study titled "Decision assist and closed loop resuscitation of hemorrhage in humans" is testing emerging new monitoring technologies for combat casualty care in volunteers undergoing a 10 mL/kg controlled hemorrhage.
	Mike Loeffelholz, Ph.D., ABMM Diagnostic virology and microbiology.
	Anthony O. Okorodudu, Ph.D., MBA, SC (ASCP), NRCC (TOXI), DABCC, FACB Intracellular cations with respect to cell membrane changes in aging.
	John R. Petersen, Ph.D. My research focuses on development of new clinical methodologies and the analytical validation of these methods.
	You-Wen Qian, M.D., Ph.D. Diagnosis of benign and malignant hematopoietic diseases using various approaches including flow cytometry immunophenotyping; Pathology Informatics, especially in laboratory information handling and clinical decision support.
	Smita Vaidya, Ph.D. Recognition of HLA epitopes by HLA antibodies.
	Natalie Williams-Bouyer, Ph.D. Antimicrobial resistance trends.

This site published by John Helms and Steve Schuenke for The Department of Pathology
Copyright © The University of Texas Medical Branch. Please review our site policies and required links